| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $203.1M | +23.9% |
| R&D Expense | $25.6M | +14.4% |
| SG&A Expense | $163.5M | +11.9% |
| Operating Income | -$33.6M | +23.5% |
| Pre-tax Income | -$57.1M | +10.1% |
| Income Tax | -$2.3M | -81.6% |
| Net Income | -$54.8M | +11.9% |
| EPS (Basic) | -$0.37 | +17.8% |
| EPS (Diluted) | -$0.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.6M | +6.2% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $40.4M | +3.1% |
| Inventory | $48.2M | +24.0% |
| Current Assets | $167.7M | +7.3% |
| Total Assets | $323.1M | +0.1% |
| Current Liabilities | $100.4M | +5.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.0M | +21.4% |
| Investing Cash Flow | $4.9M | +181.3% |
| Financing Cash Flow | $36.2M | +2342.3% |
| +17.8% |
| Long-term Debt |
| $232.1M |
| +21.6% |
| Total Liabilities | $352.7M | +7.1% |
| Stockholders' Equity | -$29.6M | -336.7% |